(Q44355177)

2 December 2017

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? (English)

1 reference

2 December 2017

pulmonary hypertension

1 reference

9

Elliott P Vichinsky

1 reference

2 December 2017

Claudia R Morris

1

1 reference

2 December 2017

Sidney M Morris

2

1 reference

2 December 2017

Ward Hagar

3

1 reference

2 December 2017

Jane Van Warmerdam

4

1 reference

2 December 2017

Susan Claster

5

1 reference

2 December 2017

Diane Kepka-Lenhart

6

1 reference

2 December 2017

Lorenzo Machado

7

1 reference

2 December 2017

Frans A Kuypers

8

1 reference

2 December 2017

language of work or name

English

0 references

publication date

5 March 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

2 December 2017

1 reference

2 December 2017

168

1 reference

2 December 2017

63-69

1 reference

2 December 2017

1

1 reference

Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies

2 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Systemic fat embolism and pulmonary hypertension in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Acute chest syndrome of sickle cell disease: new light on an old problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Regulation of enzymes of the urea cycle and arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Nitric oxide therapy in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Endothelial function in different organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Endothelin-receptor antagonists in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Insulin and the arginine paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Peroxynitrite: a putative cytotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Expression of the liver form of arginase in erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Regulation of nitric oxide production by arginine metabolic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Arginine metabolism: nitric oxide and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

The transport activity of the human cationic amino acid transporter hCAT-1 is downregulated by activation of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Increased F2Isoprostanes in the Acute Chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-967OC

10.1164/RCCM.200208-967OC

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference